nutrients-logo

Journal Browser

Journal Browser

Nutrition and Gut-Brain Axis

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutritional Epidemiology".

Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 43047

Special Issue Editor


E-Mail Website
Guest Editor
Department of Paediatrics, School of Medicine, University of Granada, Avda. Investigación 11, 18016 Granada, Spain
Interests: early nutrition and metabolic programming; neurodevelopment and brain structure and function; gut microbiota and gut–brain axis; obesity; diabetes; human milk and infant formulas; metabolomics; epigenetics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

I hope that this overview of the topic will pique your interest, and I invite you to contribute to this project.

Impressive progress has been made in characterizing the bidirectional interactions between the central nervous system, the enteric nervous system, and the gastrointestinal tract. Several exciting preclinical studies have suggested a prominent role for the gut microbiota in these gut–brain interactions. During the first years of life, the brain is exposed to environmental factors that can shape synaptic connections and neuronal circuits, with subsequent influence on behavior and learning processes; at the same time, the gut microbiota is being established and is under structural and functional development. The identification of the gut–brain axis malfunctioning during early life is of major interest because of its potential consequences. As a matter of fact, the main effects of gut microbiota perturbations on the brain may occur at times of lower diversity and instability of the gut microbiota (in infants and the elderly) and during brain development (in the perinatal and infant periods). Given the important role of perinatal influences (including nutrition) on the developing nervous system and the well-documented effects of adverse early life influences on the gut–brain axis, there is a strong rationale to implicate the gut microbiota in brain development and functioning. Thus, the nutrition–gut–brain axis can be considered to be a modulator of health, growth, and development during early life with long-term consequences until adult life. Based on animal studies, the gut microbiota appears to influence the development of emotional behavior, stress- and pain-modulation systems, and brain neurotransmitter systems; additionally, probiotics and antibiotics can alter microbiota, exerting modulatory effects on some of these neuropsychiatric pathologies. Current evidence suggests that multiple mechanisms, including endocrine and neurocrine pathways, may be involved in gut microbiota-to-brain signaling and that the brain can, in turn, alter microbial composition and behavior via the autonomic nervous system. Limited information is available on how these findings may be translated to healthy humans or to disease states (such as irritable bowel syndrome, autism, anxiety, depression, Parkinson’s disease, mood disorders, eating behavior, and chronic pain) involving the brain or the gut–brain axis and the role of diet in these processes. Diet-induced alterations in microbiota composition seem to contribute to regulating aspects of host energy balance, for instance, lipid absorption and energy harvest. It has been shown that different microbial species in the human gut could modulate fatty acid composition not only in the intestine but also in crucial tissues for host metabolism. During the prenatal period, the developing brain is first exposed to the maternal diet and gut-derived metabolites and may be exposed to intrauterine microbes. The newborn’s gut microbiota is shaped by the maternal vaginal (or skin) microbiota. The possibility that pre- and postnatal influences (including maternal diet, type of feeding, complementary food, etc.) on the microbiota can affect brain development is intriguing. An adequate nutritional and healthy microbial environment during perinatal and early life may provide windows of opportunity to reduce the risk of non-communicable and mental diseases later in life; then, in the near future, the use of targeted and individualized strategies to modulate gut microbiota establishment and functioning to favor optimal growth and neurodevelopment may be a very real possibility.

Prof. Cristina Campoy
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Nutrition
  • Gut–brain axis
  • Neurodevelopment
  • Microbiome

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 1408 KiB  
Article
Infant Gut Microbiota Associated with Fine Motor Skills
by Inmaculada Acuña, Tomás Cerdó, Alicia Ruiz, Francisco J. Torres-Espínola, Ana López-Moreno, Margarita Aguilera, Antonio Suárez and Cristina Campoy
Nutrients 2021, 13(5), 1673; https://0-doi-org.brum.beds.ac.uk/10.3390/nu13051673 - 14 May 2021
Cited by 18 | Viewed by 5061
Abstract
BACKGROUND: During early life, dynamic gut colonization and brain development co-occur with potential cross-talk mechanisms affecting behaviour. METHODS: We used 16S rRNA gene sequencing to examine the associations between gut microbiota and neurodevelopmental outcomes assessed by the Bayley Scales of Infant Development III [...] Read more.
BACKGROUND: During early life, dynamic gut colonization and brain development co-occur with potential cross-talk mechanisms affecting behaviour. METHODS: We used 16S rRNA gene sequencing to examine the associations between gut microbiota and neurodevelopmental outcomes assessed by the Bayley Scales of Infant Development III in 71 full-term healthy infants at 18 months of age. We hypothesized that children would differ in gut microbial diversity, enterotypes obtained by Dirichlet multinomial mixture analysis and specific taxa based on their behavioural characteristics. RESULTS: In children dichotomized by behavioural trait performance in above- and below-median groups, weighted Unifrac b-diversity exhibited significant differences in fine motor (FM) activity. Dirichlet multinomial mixture modelling identified two enterotypes strongly associated with FM outcomes. When controlling for maternal pre-gestational BMI and breastfeeding for up to 3 months, the examination of signature taxa in FM groups showed that Turicibacter and Parabacteroides were highly abundant in the below-median FM group, while Collinsella, Coprococcus, Enterococcus, Fusobacterium, Holdemanella, Propionibacterium, Roseburia, Veillonella, an unassigned genus within Veillonellaceae and, interestingly, probiotic Bifidobacterium and Lactobacillus were more abundant in the above-median FM group. CONCLUSIONS: Our results suggest an association between enterotypes and specific genera with FM activity and may represent an opportunity for probiotic interventions relevant to treatment for motor disorders. Full article
(This article belongs to the Special Issue Nutrition and Gut-Brain Axis)
Show Figures

Figure 1

14 pages, 721 KiB  
Article
Neurodevelopmental Outcomes and Gut Bifidobacteria in Term Infants Fed an Infant Formula Containing High sn-2 Palmitate: A Cluster Randomized Clinical Trial
by Wei Wu, Ai Zhao, Biao Liu, Wen-Hui Ye, Hong-Wen Su, Jing Li and Yu-Mei Zhang
Nutrients 2021, 13(2), 693; https://0-doi-org.brum.beds.ac.uk/10.3390/nu13020693 - 22 Feb 2021
Cited by 18 | Viewed by 4975
Abstract
A few studies suggested high stereo-specifically numbered (sn)-2 palmitate in a formula might favor the gut Bifidobacteria of infants. The initial colonization and subsequent development of gut microbiota in early life might be associated with development and later life functions of the central [...] Read more.
A few studies suggested high stereo-specifically numbered (sn)-2 palmitate in a formula might favor the gut Bifidobacteria of infants. The initial colonization and subsequent development of gut microbiota in early life might be associated with development and later life functions of the central nervous system via the microbiota–gut–brain axis, such as children with autism. This study aims to assess the hypothesized effect of increasing the amount of palmitic acid esterified in the sn-2 position in infant formula on neurodevelopment in healthy full-term infants and to explore the association of this effect with the altered gut Bifidobacteria. One hundred and ninety-nine infants were enrolled in this cluster randomized clinical trial: 66 breast-fed (BF group) and 133 formula-fed infants who were clustered and randomly assigned to receive formula containing high sn-2 palmitate (sn-2 group, n = 66) or low sn-2 palmitate (control group, n = 67), where 46.3% and 10.3% of the palmitic acid (PA) was sn-2-palmitate, respectively. Infants’ neurodevelopmental outcomes were measured by the Ages and Stages Questionnaire, third edition (ASQ-3). Stool samples were collected for the analysis of Bifidobacteria (Trial registration number: ChiCTR1800014479). At week 16, the risk of scoring close to the threshold for fine motor skills (reference: scoring above the typical development threshold) was significantly lower in the sn-2 group than the control group after adjustment for the maternal education level (p = 0.036) but did not differ significantly versus the BF group (p = 0.513). At week 16 and week 24, the sn-2 group (week 16: 15.7% and week 24: 15.6%) had a significantly higher relative abundance of fecal Bifidobacteria than the control group (week 16: 6.6%, p = 0.001 and week 24:11.2%, p = 0.028) and did not differ from the BF group (week 16: 14.4%, p = 0.674 and week 24: 14.9%, p = 0.749). At week 16, a higher relative abundance of Bifidobacteria was associated with the decreased odds of only one domain scoring close to the threshold in the formula-fed infants group (odds ratio (OR), 95% confidence interval (CI): 0.947 (0.901–0.996)). Elevating the sn-2 palmitate level in the formula improved infants’ development of fine motor skills, and the beneficial effects of high sn-2 palmitate on infant neurodevelopment was associated with the increased gut Bifidobacteria level. Full article
(This article belongs to the Special Issue Nutrition and Gut-Brain Axis)
Show Figures

Figure 1

Review

Jump to: Research

32 pages, 1553 KiB  
Review
Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications
by Ana Checa-Ros, Antonio Jeréz-Calero, Antonio Molina-Carballo, Cristina Campoy and Antonio Muñoz-Hoyos
Nutrients 2021, 13(1), 249; https://0-doi-org.brum.beds.ac.uk/10.3390/nu13010249 - 16 Jan 2021
Cited by 50 | Viewed by 18669
Abstract
Studies suggest that the bidirectional relationship existent between the gut microbiome (GM) and the central nervous system (CNS), or so-called the microbiome–gut–brain axis (MGBA), is involved in diverse neuropsychiatric diseases in children and adults. In pediatric age, most studies have focused on patients [...] Read more.
Studies suggest that the bidirectional relationship existent between the gut microbiome (GM) and the central nervous system (CNS), or so-called the microbiome–gut–brain axis (MGBA), is involved in diverse neuropsychiatric diseases in children and adults. In pediatric age, most studies have focused on patients with autism. However, evidence of the role played by the MGBA in attention deficit/hyperactivity disorder (ADHD), the most common neurodevelopmental disorder in childhood, is still scanty and heterogeneous. This review aims to provide the current evidence on the functioning of the MGBA in pediatric patients with ADHD and the specific role of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in this interaction, as well as the potential of the GM as a therapeutic target for ADHD. We will explore: (1) the diverse communication pathways between the GM and the CNS; (2) changes in the GM composition in children and adolescents with ADHD and association with ADHD pathophysiology; (3) influence of the GM on the ω-3 PUFA imbalance characteristically found in ADHD; (4) interaction between the GM and circadian rhythm regulation, as sleep disorders are frequently comorbid with ADHD; (5) finally, we will evaluate the most recent studies on the use of probiotics in pediatric patients with ADHD. Full article
(This article belongs to the Special Issue Nutrition and Gut-Brain Axis)
Show Figures

Graphical abstract

31 pages, 1915 KiB  
Review
Nutrition, Microbiota and Role of Gut-Brain Axis in Subjects with Phenylketonuria (PKU): A Review
by Elvira Verduci, Maria Teresa Carbone, Elisa Borghi, Emerenziana Ottaviano, Alberto Burlina and Giacomo Biasucci
Nutrients 2020, 12(11), 3319; https://0-doi-org.brum.beds.ac.uk/10.3390/nu12113319 - 29 Oct 2020
Cited by 21 | Viewed by 13176
Abstract
The composition and functioning of the gut microbiota, the complex population of microorganisms residing in the intestine, is strongly affected by endogenous and exogenous factors, among which diet is key. Important perturbations of the microbiota have been observed to contribute to disease risk, [...] Read more.
The composition and functioning of the gut microbiota, the complex population of microorganisms residing in the intestine, is strongly affected by endogenous and exogenous factors, among which diet is key. Important perturbations of the microbiota have been observed to contribute to disease risk, as in the case of neurological disorders, inflammatory bowel disease, obesity, diabetes, cardiovascular disease, among others. Although mechanisms are not fully clarified, nutrients interacting with the microbiota are thought to affect host metabolism, immune response or disrupt the protective functions of the intestinal barrier. Similarly, key intermediaries, whose presence may be strongly influenced by dietary habits, sustain the communication along the gut-brain-axis, influencing brain functions in the same way as the brain influences gut activity. Due to the role of diet in the modulation of the microbiota, its composition is of high interest in inherited errors of metabolism (IEMs) and may reveal an appealing therapeutic target. In IEMs, for example in phenylketonuria (PKU), since part of the therapeutic intervention is based on chronic or life-long tailored dietetic regimens, important variations of the microbial diversity or relative abundance have been observed. A holistic approach, including a healthy composition of the microbiota, is recommended to modulate host metabolism and affected neurological functions. Full article
(This article belongs to the Special Issue Nutrition and Gut-Brain Axis)
Show Figures

Figure 1

Back to TopTop